Literature DB >> 19419406

Electrocardiographic body surface mapping: potential tool for the detection of transient myocardial ischemia in the 21st century?

Monique R Robinson1, Nicholas Curzen.   

Abstract

Coronary artery disease (CAD) is one of the leading causes of cardiovascular mortality and morbidity worldwide. CAD presents as a wide spectrum of clinical disease from stable angina to ST segment elevation myocardial infarction. The 12-lead electrocardiogram (ECG) has been the main tool for the diagnosis of these events for almost a century but is limited in its diagnostic ability. For patients with suspected angina, the exercise tolerance test is often used to provoke and detect stress-induced ischemia but does not provide a definitive answer in a substantial proportion of patients. Body surface mapping (BSM) is a technique that samples multiple points around the thorax to provide a more comprehensive electrocardiographic data set than the conventional 12-lead ECG. Moreover, recent preliminary data demonstrate that BSM can detect and display transient regional myocardial ischemia in an intuitive fashion, employing subtraction color mapping, making it potentially valuable for diagnosing CAD causing transient regional ischemia. Research is ongoing to determine the full extent of its utility.

Entities:  

Mesh:

Year:  2009        PMID: 19419406      PMCID: PMC6932397          DOI: 10.1111/j.1542-474X.2009.00284.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  49 in total

1.  Interindividual variability of multilead electrocardiographic recordings: influence of heart position.

Authors:  R Hoekema; G J Uijen; L van Erning; A van Oosterom
Journal:  J Electrocardiol       Date:  1999-04       Impact factor: 1.438

2.  [Research on the origin of the maxima and minima of the potential which appears at the trunk surface during cardiac activity].

Authors:  B TACCARDI; G MARCHETTI
Journal:  J Physiol (Paris)       Date:  1963

3.  Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.

Authors:  Jean-Pierre Bassand; Christian W Hamm; Diego Ardissino; Eric Boersma; Andrzej Budaj; Francisco Fernández-Avilés; Keith A A Fox; David Hasdai; E Magnus Ohman; Lars Wallentin; William Wijns
Journal:  Eur Heart J       Date:  2007-06-14       Impact factor: 29.983

4.  Relation between the ventriculographic silhouette and topography of thoracic potential in coronary artery disease.

Authors:  L G Horan; H A Killam; N C Flowers; M R Sridharan; R Harp; P C Orander; R C Hand
Journal:  Am J Cardiol       Date:  1989-08-02       Impact factor: 2.778

5.  Body surface potential maps with low-level exercise in isolated left anterior descending coronary artery disease.

Authors:  T J Montague; D E Johnstone; C A Spencer; R M Miller; B R Mackenzie; M J Gardner; B M Horacek
Journal:  Am J Cardiol       Date:  1988-02-01       Impact factor: 2.778

6.  Body surface distribution of electrical potential during atrial depolarization and repolarization.

Authors:  D M Mirvis
Journal:  Circulation       Date:  1980-07       Impact factor: 29.690

7.  Automated production of contour maps for electrophysiology. II. Triangulation, verification, and organization of the geometric model.

Authors:  R C Barr; T M Gallie; M S Spach
Journal:  Comput Biomed Res       Date:  1980-04

8.  The relationship between electrical axis by 12-lead electrocardiogram and anatomical axis of the heart by cardiac magnetic resonance in healthy subjects.

Authors:  Henrik Engblom; John E Foster; Thomas N Martin; Bjoern Groenning; Olle Pahlm; Henry J Dargie; Galen S Wagner; Håkan Arheden
Journal:  Am Heart J       Date:  2005-09       Impact factor: 4.749

9.  Body surface potential mapping of ST-segment shift in patients undergoing percutaneous transluminal coronary angioplasty. Correlations with the ECG and vectorcardiogram.

Authors:  M Shenasa; D Hamel; J Nasmith; R Nadeau; J L Dutoy; D Derome; P Savard
Journal:  J Electrocardiol       Date:  1993-01       Impact factor: 1.438

10.  Application of body surface mapping to exercise testing: S-T80 isoarea maps in patients with coronary artery disease.

Authors:  F G Yanowitz; G M Vincent; R L Lux; M Merchant; L S Green; J A Abildskov
Journal:  Am J Cardiol       Date:  1982-11       Impact factor: 2.778

View more
  6 in total

1.  XML-BSPM: an XML format for storing Body Surface Potential Map recordings.

Authors:  Raymond R Bond; Dewar D Finlay; Chris D Nugent; George Moore
Journal:  BMC Med Inform Decis Mak       Date:  2010-05-14       Impact factor: 2.796

2.  Body Surface Potential Mapping: Contemporary Applications and Future Perspectives.

Authors:  Jake Bergquist; Lindsay Rupp; Brian Zenger; James Brundage; Anna Busatto; Rob S MacLeod
Journal:  Hearts (Basel)       Date:  2021-11-05

Review 3.  Computational techniques for ECG analysis and interpretation in light of their contribution to medical advances.

Authors:  Aurore Lyon; Ana Mincholé; Juan Pablo Martínez; Pablo Laguna; Blanca Rodriguez
Journal:  J R Soc Interface       Date:  2018-01       Impact factor: 4.118

4.  ST-segment changes in high-resolution body surface potential maps measured during exercise to assess myocardial ischemia: a pilot study.

Authors:  Michał Kania; Rajmund Zaczek; Heriberto Zavala-Fernandez; Dariusz Janusek; Małgorzata Kobylecka; Leszek Królicki; Grzegorz Opolski; Roman Maniewski
Journal:  Arch Med Sci       Date:  2014-07-02       Impact factor: 3.318

Review 5.  Multisensor Systems and Arrays for Medical Applications Employing Naturally-Occurring Compounds and Materials.

Authors:  Rasa Pauliukaite; Edita Voitechovič
Journal:  Sensors (Basel)       Date:  2020-06-23       Impact factor: 3.576

6.  Noninvasive Assessment of Atrial Fibrillation Complexity in Relation to Ablation Characteristics and Outcome.

Authors:  Marianna Meo; Thomas Pambrun; Nicolas Derval; Carole Dumas-Pomier; Stéphane Puyo; Josselin Duchâteau; Pierre Jaïs; Mélèze Hocini; Michel Haïssaguerre; Rémi Dubois
Journal:  Front Physiol       Date:  2018-07-17       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.